Genotype and phenotype characterization of primary hypertrophic osteoarthropathy type 2 and chronic enteropathy associated with SLCO2A1: Report of two cases and literature review

Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies

(2022) Mark E. McAlindon   CURRENT OPINION IN GASTROENTEROLOGY

Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy

(2021) Yang Xu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

SLCO2A1 gene is the causal gene for both primary hypertrophic osteoarthropathy and hereditary chronic enteropathy

(2021) Junji Umeno et al.   Journal of Orthopaedic Translation

Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature

(2019) Qiang Wang et al.   Orphanet Journal of Rare Diseases

Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn’s disease

(2018) Junji Umeno et al.   JOURNAL OF GASTROENTEROLOGY

Distinction between Chronic Enteropathy Associated with the SLCO2A1 Gene and Crohn's Disease

(2018) Shunichi Yanai et al.   Gut and Liver

Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention

(2017) Shan-Shan Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Chronic Enteropathy Associated With SLCO2A1 Gene [CEAS]—Characterisation of an Enteric Disorder to be Considered in the Differential Diagnosis of Crohn’s Disease

(2017) Naoki Hosoe et al.   Journal of Crohns & Colitis

Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the SLCO2A1 gene

(2016) Z.-T. Li et al.   BRITISH JOURNAL OF DERMATOLOGY

Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications

(2016) Sam Harirforoosh et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter

(2015) Junji Umeno et al.   PLoS Genetics

Protter: interactive protein feature visualization and integration with experimental proteomic data

(2013) Ulrich Omasits et al.   BIOINFORMATICS

Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic Osteoarthropathy

(2011) Zhenlin Zhang et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Molecular cloning and characterization of the porcine prostaglandin transporter (SLCO2A1): evaluation of its role in F4 mediated neonatal diarrhoea

(2009) Mario Van Poucke et al.   BMC GENETICS

Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy

(2008) Sandeep Uppal et al.   NATURE GENETICS